Section 4: Clinical Pharmacy Services

4CPS-047

ASSESSING THE IMPACT OF ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN HOSPITALS: ROLE OF HOSPITAL PHARMACISTS. (submitted in 2019)

4CPS-046

MONITORING THE PRESCRIPTION OF NEW ANTIBIOTICS: THE WORK OF THE ANTIMICROBIAL STEWARDSHIP TEAM IN A THIRD LEVEL HOSPITAL (submitted in 2019)

4CPS-045

COST EFFECTIVENESS ANALYSIS OF MEROPENEM DOSE OPTIMISATION IN CRITICAL PATIENTS (submitted in 2019)

4CPS-044

THE ROUTINE USE OF ANTIBIOTICS AFTER INSERTION OF A CARDIAC IMPLANTABLE ELECTRONIC DEVICE (CIED): EVIDENCE AND CURRENT PRACTICE (submitted in 2019)

4CPS-043

EFFECTIVENESS OF A NEW INTERNAL PROTOCOL FOR DOSAGE OF VANCOMYCIN IN NEONATES (submitted in 2019)

4CPS-042

PHARMACIST'S MISSION IN INFECTION MANAGEMENT : EVALUATION OF IMPROVEMENT ACTIONS (submitted in 2019)

4CPS-041

PHARMACIST LED ANTIMICROBIAL STEWARDSHIP PROGRAMME (submitted in 2019)

4CPS-040

ADEQUACY OF ANTIBIOTIC PRESCRIPTIONS IN A NURSING HOME (submitted in 2019)

4CPS-039

NOSOCOMIAL INFECTION BY MULTIRESISTANT PATHOGENS IN KIDNEY TRANSPLANTED PATIENTS (submitted in 2019)

4CPS-038

STABILITY TO HIGH TEMPERATURES OF THE ANTIMICROBIALS USED IN OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY PROGRAMMES (submitted in 2019)

4CPS-037

CLINICAL OUTCOME IN PAEDIATRIC INTENSIVE CARE UNIT PATIENTS TREATED WITH VANCOMYCIN (submitted in 2019)

4CPS-036

PHARMACEUTICAL INTERVENTIONS IN A SMALL HOSPITAL (submitted in 2019)

4CPS-035

CLINICAL PHARMACOKINETICS OF VANCOMYCIN IN NEUTROPENIC PATIENTS (submitted in 2019)

4CPS-034

IS IT POSSIBLE TO RATIONALISE THE ANTIBIOTIC USE AMONG HOSPITALISED PATIENTS BY CLINICAL PHARMACISTS’ ACTIVITY? (submitted in 2019)

4CPS-033

OFF-LABEL USE OF NEBULISED AZTREONAM LYSINE IN PATIENTS WITH CHRONIC GRAM-NEGATIVE BACTERIAL LUNG COLONISATION (submitted in 2019)

Pages